VENTURE CAPITAL
Dynamic
MULTI-DIMENSIONAL INVESTMENT
At Shorooq, we adopt a fresh approach to venture capital, investing in founders as early as the idea or pre-seed stage. Our value-focused strategy is unique to our ecosystem and, combined with deep regional knowledge through locally-embedded partners, enables us to identify and nurture high-potential founders and startups.
With a meticulous deal-making process, we seek out exceptional outliers—those founders with the potential to become the most successful leaders in their industries. This comprehensive and thoughtful approach ensures that we not only support innovation but also help shape the future landscape of the Middle Eastern startup ecosystem.
BEDAYA FUNDS
We live our approach, and our Venture Capital funds are entitled Bedaya Fund 0, I & II.
‘Bedaya’ means ‘beginnings’. This name describes our new ventures and the approach of the founders we invest in.
RECENT NEWS IN VENTURE CAPITAL
Explore the latest achievements and strategic investments by Shorooq Partners, showcasing how we are driving innovation and growth in the venture capital landscape.
Capital markets as a viable path for exits in MENA
A roundtable event, co-hosted by Shorooq and London Stock Exchange (LSEG), brought together key stakeholders at Abu Dhabi Global Market (ADGM) HQ to explore the challenges and opportunities of utilizing capital markets for tech companies as a viable exit path in the MENA region.
Capital markets as a viable path for exits in MENA
A roundtable event, co-hosted by Shorooq and London Stock Exchange (LSEG), brought together key stakeholders at Abu Dhabi Global Market (ADGM) HQ to explore the challenges and opportunities of utilizing capital markets for tech companies as a viable exit path in the MENA region.
Proteinea's Pioneering Approach to AI-Designed Therapeutics
Proteinea’s application of AI in protein engineering and biotherapeutics design exemplifies the advancements we aim to foster. With the development of Ankh, an unprecedented protein transformer, Proteinea is advancing healthcare to become more proactive, precise, and personalized. This partnership underscores our commitment to nurturing innovations that promise a healthier tomorrow.
Proteinea's Pioneering Approach to AI-Designed Therapeutics
Proteinea’s application of AI in protein engineering and biotherapeutics design exemplifies the advancements we aim to foster. With the development of Ankh, an unprecedented protein transformer, Proteinea is advancing healthcare to become more proactive, precise, and personalized. This partnership underscores our commitment to nurturing innovations that promise a healthier tomorrow.
Shorooq Partners Announces New Investment in Intelmatix
We are thrilled to announce our latest investment achievements and our unwavering commitment to fostering innovation across the Middle East. Our recent ventures highlight our leadership in the Artificial Intelligence (AI) and deep tech sectors, reinforcing our dedication to supporting groundbreaking startups and driving technological advancements in the region.
Shorooq Partners Announces New Investment in Intelmatix
We are thrilled to announce our latest investment achievements and our unwavering commitment to fostering innovation across the Middle East. Our recent ventures highlight our leadership in the Artificial Intelligence (AI) and deep tech sectors, reinforcing our dedication to supporting groundbreaking startups and driving technological advancements in the region.